Site icon fundsforNGOs

RFAs: CaixaImpulse Health Innovation Programme in Spain and Portugal

Open Call for Quality Improvement Grants Program in Japan

Deadline: 19-Feb-2026

The CaixaImpulse Health Innovation Call supports the translation of high-potential health research into real-world solutions through a structured, milestone-based funding programme. It targets life sciences and human health innovations in therapeutics, medical devices, diagnostics, and digital health, offering up to €500,000 across three progressive stages.

Overview of the CaixaImpulse Health Innovation Call

The CaixaImpulse Health Innovation Call provides a structured pathway to advance promising health innovations from early research stages toward market and clinical application.

The programme is designed to bridge the gap between scientific research and real-world healthcare impact by combining financial support with a clear, milestone-driven development framework.

It focuses on accelerating innovations that address unmet medical needs and deliver measurable benefits for patients and healthcare systems.

What Is CaixaImpulse?

CaixaImpulse is a health innovation acceleration programme that supports projects in life sciences and human health with strong innovation potential.

The programme emphasizes:

Market-oriented research

Technology transfer and valorisation

Evidence-based project progression

Accountability through predefined milestones

Rather than offering one-off grants, CaixaImpulse supports projects across multiple stages of maturity, enabling sustained development and validation.

Priority Areas and Types of Innovations Supported

The call is particularly suited to projects in:

Therapeutics, including novel drugs and treatment approaches

Medical devices for diagnosis, treatment, or monitoring

Diagnostics technologies improving detection and decision-making

Digital health solutions such as software, platforms, or data-driven tools

All supported projects must demonstrate a clear innovation component and a realistic pathway toward market transfer or implementation in healthcare settings.

Funding Structure and Financial Support

Three-Stage Funding Model

Financial support is tailored to the maturity level of each project and distributed across three stages:

Stage 1 funding of up to €50,000

Stage 2 funding of up to €150,000

Stage 3 funding of up to €500,000

Projects that successfully progress through multiple stages may receive cumulative funding across stages.

Milestone-Based Payments

Funding is disbursed in instalments linked to:

Achievement of predefined technical or commercial milestones

Submission and approval of progress reports

This structure ensures continuous monitoring, accountability, and steady project advancement.

Eligible Costs and Use of Funds

Funding can be used to support activities essential for innovation development and market readiness, including:

Subcontracting specialised services related to valorisation or regulatory strategy

Business development and market viability studies

Hiring personnel directly involved in project execution

Purchasing consumables, materials, and supplies for testing and experimental development

Travel and representation expenses linked to project activities

For projects in stages two and three, part of the funding may also be allocated to overhead costs.

Who Is Eligible to Apply?

Eligible Institutions

Applicants must be public-sector or non-profit legal entities based in Spain or Portugal, including:

Universities

Research and technology centres

Hospitals and healthcare institutions

Foundations

Biomedical and health research institutions

The applicant institution must own or co-own the research assets generated by the project.

Established companies are not eligible to apply or participate as partner institutions.

Application Limits

Institutions may submit multiple applications, but:

Each application must be linked to a distinct asset

Each asset must originate from a different research project

Project Leadership Requirements

Project leaders must meet the following criteria:

Hold tertiary education, such as university degree, doctorate, or professorship

Be professionally connected to the applicant institution

Dedicate the majority of their professional time to the proposed project

Submit only one application as project leader

This ensures strong leadership commitment and focused project management throughout the programme.

How the CaixaImpulse Programme Works

Step-by-Step Process

Project selection based on innovation potential and market relevance

Allocation to the appropriate funding stage based on maturity

Definition of technical, regulatory, and commercial milestones

Periodic reporting and milestone assessment

Progression to subsequent stages upon successful evaluation

This structured approach reduces risk and supports efficient innovation translation.

Why the CaixaImpulse Health Innovation Call Matters

The programme plays a critical role in strengthening health innovation ecosystems by:

Reducing the gap between research and market

Supporting early-stage technologies often overlooked by traditional funding

Encouraging responsible and patient-focused innovation

Enhancing the impact of public and non-profit research

It enables scientific excellence to evolve into tangible healthcare solutions.

Common Mistakes to Avoid

Applying without a clear innovation or market transfer pathway

Underestimating the importance of milestones and reporting

Submitting projects without institutional ownership of assets

Assuming company participation is allowed

Overlooking the need for dedicated project leadership

Frequently Asked Questions (FAQ)

1. What is the maximum funding available under CaixaImpulse?

Projects can receive up to €500,000 in stage three, with cumulative funding possible across all stages.

2. Is CaixaImpulse a single grant or a multi-stage programme?

It is a multi-stage programme with funding linked to project maturity and milestone achievement.

3. Can private companies apply or participate?

No. Established companies are not eligible to apply or participate as partner institutions.

4. Which countries are eligible?

Applicant institutions must be based in Spain or Portugal.

5. What types of costs can be covered?

Eligible costs include subcontracting, personnel, consumables, market studies, travel, and limited overheads in later stages.

6. Can an institution submit more than one application?

Yes, provided each application is linked to a distinct asset from a different research project.

7. Who can act as project leader?

Qualified individuals with tertiary education who are professionally connected to the applicant institution and dedicated to the project.

Conclusion

The CaixaImpulse Health Innovation Call offers a robust, milestone-driven framework for transforming high-potential health research into real-world solutions. By combining staged financial support with strong accountability and innovation focus, the programme empowers research institutions in Spain and Portugal to accelerate impactful advances in therapeutics, medical devices, diagnostics, and digital health.

For more information, visit ”La Caixa” Foundation.

Exit mobile version